UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

Gene therapy, 2011-11, Vol.18 (11), p.1070-1077

2011

Volltextzugriff (PDF)

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

The Journal of infectious diseases, 1998-07, Vol.178 (1), p.92-100

1998

Volltextzugriff (PDF)

Inducing Humoral and Cellular Responses to Multiple Sporozoite and Liver-Stage Malaria Antigens Using Exogenous Plasmid DNA

Infection and Immunity, 2013-10, Vol.81 (10), p.3709-3720

2013

Volltextzugriff (PDF)

Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo

Gene therapy, 2010-01, Vol.17 (1), p.72-82

2010

Volltextzugriff (PDF)

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device

Gene therapy, 2011-03, Vol.18 (3), p.258-265

2011

Volltextzugriff (PDF)

DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques

Cancer gene therapy, 2013-12, Vol.20 (12), p.652-662

2013

Volltextzugriff (PDF)

DNA vaccination: antigen presentation and the induction of immunity

Journal of leukocyte biology, 2000-12, Vol.68 (6), p.793-806

2000

Volltextzugriff (PDF)

Gene Inoculation Generates Immune Responses Against Human Immunodeficiency Virus Type 1

Proceedings of the National Academy of Sciences - PNAS, 1993-05, Vol.90 (9), p.4156-4160

1993

Volltextzugriff (PDF)

Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation

Cancer gene therapy, 2006-10, Vol.13 (10), p.969-974

2006

Volltextzugriff (PDF)

Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1 env/rev DNA Vaccine Induces Antigen-Specific Proliferation and Lymphocyte Production of β-Chemokines

The Journal of infectious diseases, 2000-02, Vol.181 (2), p.476-483

2000

Volltextzugriff (PDF)

Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

Human vaccines & immunotherapeutics, 2015-08, Vol.11 (8), p.1945-1953

2015

Volltextzugriff (PDF)

DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

Journal of Virology, 2000-12, Vol.74 (23), p.11173-11180

2000

Volltextzugriff (PDF)

CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine

Vaccine, 2020-03, Vol.38 (11), p.2626-2635

2020

Volltextzugriff (PDF)

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

Nature biotechnology, 1997-07, Vol.15 (7), p.641-646

1997

Volltextzugriff (PDF)

Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model

Cancer gene therapy, 2014-12, Vol.21 (12), p.507-517

2014

Volltextzugriff (PDF)

Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr

Journal of Virology, 1997-09, Vol.71 (9), p.6339-6347

1997

Volltextzugriff (PDF)

Serum Vpr Regulates Productive Infection and Latency of Human Immunodeficiency Virus Type 1

Proceedings of the National Academy of Sciences - PNAS, 1994-11, Vol.91 (23), p.10873-10877

1994

Volltextzugriff (PDF)

Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge

Mucosal immunology, 2016-01, Vol.9 (1), p.13-23

2016

Volltextzugriff (PDF)

The Glucocorticoid Receptor Type II Complex is a Target of the HIV-1 vpr Gene Product

Proceedings of the National Academy of Sciences - PNAS, 1995-04, Vol.92 (8), p.3621-3625

1995

Volltextzugriff (PDF)

P19-49. Modulation of vaccine induced responses through CTLA-4 and 41BB enhances protection in macaques following SIVmac251 challenge

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P369-P369, Article P369

2009

Volltextzugriff (PDF)

P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P28-P28, Article P28

2009

Volltextzugriff (PDF)

Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency

Journal of Virology, 1995-02, Vol.69 (2), p.1243-1252

1995

Volltextzugriff (PDF)

HIV-1 Vpr Transactivates LTR-Directed Expression through Sequences Present within −278 to −176 and Increases Virus Replication in Vitro

Virology (New York, N.Y.), 2001-10, Vol.289 (2), p.334-342

2001

Volltextzugriff (PDF)

Induction of cell differentiation by human immunodeficiency virus 1 vpr

Cell, 1993-02, Vol.72 (4), p.541-550

1993

Volltextzugriff (PDF)

Hydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protection

Cancer gene therapy, 2013-10, Vol.20 (10), p.552-563

2013

Volltextzugriff (PDF)

1 – 25 von 2.288

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.048)
Mit Volltextzugriff
(1.754)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(2.241)
Französisch
(30)
Deutsch
(12)
Hebräisch
(2)
Russisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.537)
Life Sciences & Biomedicine
(1.324)
Humans
(1.121)
Female
(676)
Biological And Medical Sciences
(638)
Male
(583)
Medical Sciences
(501)
Animals
(369)
Middle Aged
(351)
Adult
(316)
Aged
(281)
Neurosciences & Neurology
(205)
Immunology
(193)
Mice
(177)
Fundamental And Applied Biological Sciences. Psychology
(162)
Physical Sciences
(155)
Clinical Neurology
(154)
Biochemistry & Molecular Biology
(142)
Adolescent
(139)
Neurology
(131)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

Inducing Humoral and Cellular Responses to Multiple Sporozoite and Liver-Stage Malaria Antigens Using Exogenous Plasmid DNA

Plasmids encoding the mucosal chemokines CCL27 and CCL28 are effective adjuvants in eliciting antigen-specific immunity in vivo

Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device

DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques

DNA vaccination: antigen presentation and the induction of immunity

Gene Inoculation Generates Immune Responses Against Human Immunodeficiency Virus Type 1

Regression of subcutaneous B16 melanoma tumors after intratumoral delivery of an IL-15-expressing plasmid followed by in vivo electroporation

Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1 env/rev DNA Vaccine Induces Antigen-Specific Proliferation and Lymphocyte Production of β-Chemokines

Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

DNA Vaccines Encoding Interleukin-8 and RANTES Enhance Antigen-Specific Th1-Type CD4+ T-Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 In Vivo

CCR10 expression is required for the adjuvant activity of the mucosal chemokine CCL28 when delivered in the context of an HIV-1 Env DNA vaccine

Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model

Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr

Serum Vpr Regulates Productive Infection and Latency of Human Immunodeficiency Virus Type 1

Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge

The Glucocorticoid Receptor Type II Complex is a Target of the HIV-1 vpr Gene Product

P19-49. Modulation of vaccine induced responses through CTLA-4 and 41BB enhances protection in macaques following SIVmac251 challenge

P03-11. DNA vaccination with IL-12 lowers viral replication following SIVmac251 challenge

Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency

HIV-1 Vpr Transactivates LTR-Directed Expression through Sequences Present within −278 to −176 and Increases Virus Replication in Vitro

Induction of cell differentiation by human immunodeficiency virus 1 vpr

Hydrodynamic immunization leads to poor CD8 T-cell expansion, low frequency of memory CTLs and ineffective antiviral protection

Suchergebnisse filtern